Using 5 consecutive years of NICE guidance to describe the characteristics and influencing factors on the economic evaluation of orphan oncology drugs

Overview of attention for article published in Frontiers in Public Health, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 26 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 20,418 followers.

RT @GrupoOrpharSEFH: Análisis del enfoque de evaluación económica del NICE en los #MedicamentosHuérfanos oncológicos. 🔗https://t.co/HDd1Lz…

13 Oct 2022

Reply Repost Favourite

RT @joseluis_pa: Orphan oncology drugs are comprehensively evaluated in multiple additional dimensions, which include life-extending benefi…

13 Oct 2022

Reply Repost Favourite

Orphan oncology drugs are comprehensively evaluated in multiple additional dimensions, which include life-extending benefits, and innovation. https://t.co/Ckb6FFrlb3

13 Oct 2022

Reply Repost Favourite

Análisis del enfoque de evaluación económica del NICE en los #MedicamentosHuérfanos oncológicos. 🔗https://t.co/HDd1LzPM0i

13 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.